Abstract:Bone morphogenetic protein-2 (BMP-2) has been widely used as an effective growth factor in bone tissue engineering. However, large amounts of BMP-2 are required to induce new bone and the resulting side effects limit its clinical application. Sulfated polysaccharides, such as native heparin, and heparan sulfate have been found to modulate BMP-2 bioactivity and play pivotal roles in bone metabolism. Whereas the direct role of chitosan modified with sulfate group in BMP-2 signaling has not been reported till now. In the present study, several sulfated chitosans with different positions were synthesized by regioselective reactions firstly. Using C2C12 myoblast cells as in vitro models, the enhanced bioactivity of BMP-2 was attributed primarily to the stimulation from 6-O-sulfated chitosan (6SCS), while 2-N-sulfate was subsidiary group with less activation. Low dose of 2-N, 6-O-sulfated chitosan (26SCS) showed significant enhancement on the alkaline phosphatase (ALP) activity and the mineralization formation induced by BMP-2, as well as the expression of ALP and osteocalcin mRNA. Moreover, increased chain-length and further sulfation on 26SCS also resulted in a higher ALP activity. Dose-dependent effects on BMP-2 bioactivity were observed in both sulfated chitosan and heparin. Compared with native heparin, 26SCS showed much stronger simultaneous effects on the BMP-2 bioactivity at low dose. Stimulated secreted Noggin protein failed to block the function of BMP-2 in the presence of 26SCS. The BMP-2 ligand bound to its receptor was enhanced by low dose of 26SCS, whereas weakened by the increasing amounts of 26SCS. Furthermore, simultaneous administration of BMP-2 and 26SCS in vivo dose-dependently induced larger amounts of ectopic bone formation compared with BMP-2 alone. These findings clearly indicate that 26SCS is a more potent enhancer for BMP-2 bioactivity to induce osteoblastic differentiation in vitro and in vivo by promoting BMP-2 signaling pathway, suggesting that 26SCS could be used as the synergistic factor of BMP-2 for bone regeneration.

Enhancing Bioactivity of Chitosan Film for Osteogenesis and Wound Healing by Covalent Immobilization of BMP-2 or FGF-2

Co-transfection with BMP2 and FGF2 Via Chitosan Nanoparticles Potentiates Osteogenesis in Human Adipose-Derived Stromal Cells in Vitro.

A Novel Grapheme Oxide-Modified Collagen-Chitosan Bio-Film for Controlled Growth Factor Release in Wound Healing Applications.

Immobilization of BMP-2 on a nano-hydroxyapatite-coated titanium surface using a chitosan calcium chelating agent

Enhanced Osteogenesis of Bone Morphology Protein-2 in 2-N,6-o-sulfated Chitosan Immobilized PLGA Scaffolds.

Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.

Immobilization of fibronectin in chitosan substrates improves cell adhesion and proliferation

Artificial Cilia for Soft and Stable Surface Covalent Immobilization of Bone Morphogenetic Protein-2

Enhanced Loading and Controlled Release of Rhbmp-2 in Thin Mineralized Collagen Coatings with the Aid of Chitosan Nanospheres and Its Biological Evaluations.

Biomimetic ECM coatings for controlled release of rhBMP-2: construction and biological evaluation

BMP-2 Plasmid DNA-loaded Chitosan Films – A New Strategy for Bone Engineering

Accelerated Bone Regenerative Efficiency by Regulating Sequential Release of BMP-2 and VEGF and Synergism with Sulfated Chitosan.

Enhancement of BMP-2-mediated angiogenesis and osteogenesis by 2-N,6-O-sulfated chitosan in bone regeneration

BMP2-encapsulated chitosan coatings on functionalized Ti surfaces and their performance in vitro and in vivo

Reparation of Sulfonated Chitosan and Its Ability to Protect Bfgf Activites

Synergistic effect between 2-N,6-O-sulfonated chitosan and bone morphogenetic protein-2

A Chitin Film Containing Basic Fibroblast Growth Factor with a Chitin-Binding Domain As Wound Dressings.

Influence of the Degree of Deacetylation of Chitosan and BMP-2 Concentration on Biocompatibility and Osteogenic Properties of BMP-2/PLA Granule-Loaded Chitosan/β-Glycerophosphate Hydrogels

Enhanced Biocompatibility and Improved Osteogenesis of Coralline Hydroxyapatite Modified by Bone Morphogenetic Protein 2 Incorporated into a Biomimetic Coating.

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

Heparinized chitosan stabilizes the bioactivity of BMP-2 and potentiates the osteogenic efficacy of demineralized bone matrix